Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic medicines combination study in cancer
2016-001830-91Phase 3Unknown
- Sponsor
- Health Clinics Limited
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of metformin, atorvastatin, doxycycline and mebendazole in cancer (2 arms), sponsored by Health Clinics Limited. Primary endpoint: Overall survival. Status: unknown.
02
Drugs
metforminatorvastatindoxycyclinemebendazole
03
Conditions
cancer
Beyond the preview
Go deeper on 2016-001830-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001830-91.